Alembic receives FDA OK for generic ArranonNelarabine is indicated for the treatment of patients with T-cell acute lymphoblastic leukemia and lymphoma in certain patients. Sandoz receives FDA approval for Eyelea biosimilar Enzeevu is approved to treat neovascular age-related macular degeneration. FDA gives Lupin nod for generic Pred Forte, tentative OK for generic Descovy The company received approval for generic Pred Forte and generic Descovy. Mallinckrodt to sell Therakos business to CVC for $925M Therakos is a fully integrated extracorporeal photopheresis delivery system for autologous immunomodulatory therapy. ANI Pharmaceuticals announces proposed convertible senior notes offering ANI also expects to grant the initial purchasers of the notes an option to purchase. Somerset Pharma expands generic portfolio Somerset Pharma is introducing six new generic products. Alembic releases generic Effexor Generic Effexor is used for treating various mental health conditions. Novartis files lawsuit against FDA over generic Entresto The complaint follows the FDA granting permission to MSN Laboratories for an Entresto generic product. Dr. Reddy’s receives positive CHMP opinion from EMA for proposed rituximab biosimilar Rituximab is used to treat various cancers. FDA gives Amneal OK for potassium phosphates injection IV bags The drug is a phosphorus replacement product indicated to correct hypophosphatemia First Previous 23 24 25 26 27 Next Last
